Biotech · Private company
Lakefront Biotherapeutics NV
Track this companyFree. Adds Lakefront Biotherapeutics NV to your Dealase workspace and tells you when its record changes.
Clinical trials251 recruiting or active
Pipeline programs13From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline13
- FilgotinibPhase 3 · Crohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- FilgotinibPhase 3 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- GLPG CAR T-cell therapyPhase 3 · Hematological MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- GLPG1690Phase 3 · Idiopathic Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- FilgotinibPhase 2 · Inflammatory Bowel DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- FilgotinibPhase 2 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- GLPG1690Phase 2 · Systemic SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- GLPG1972Phase 2 · OsteoarthritisClinicalTrials.gov · fetched Nov 12, 2026
- GLPG3667Phase 2 · DermatomyositisClinicalTrials.gov · fetched Nov 12, 2026
- GLPG3667Phase 2 · Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- GLPG5101Phase 2 · Relapsed/Refractory B-cell Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- GLPG3970Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- SulfasalazinePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell TherapiesPHASE3 · RECRUITING · started Sep 9, 2024ClinicalTrials.gov NCT06652633 · fetched Nov 12, 2026
- A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus ErythematosusPHASE2 · COMPLETED · started Jun 28, 2023ClinicalTrials.gov NCT05856448 · fetched Nov 12, 2026
- A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With DermatomyositisPHASE2 · COMPLETED · started Feb 27, 2023ClinicalTrials.gov NCT05695950 · fetched Nov 12, 2026
- A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in RemissionPHASE3 · TERMINATED · started Jul 26, 2022ClinicalTrials.gov NCT05479058 · fetched Nov 12, 2026
- A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin LymphomaPHASE1_PHASE2 · TERMINATED · started Mar 9, 2022ClinicalTrials.gov NCT06561425 · fetched Nov 12, 2026
- Drug-drug Interaction Study with GLPG3970 and Sulfasalazine in Adult, Healthy SubjectsPHASE1 · COMPLETED · started Jan 11, 2021ClinicalTrials.gov NCT04720183 · fetched Nov 12, 2026
- Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy ParticipantsPHASE1 · COMPLETED · started Nov 4, 2020ClinicalTrials.gov NCT04608344 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD TherapyPHASE3 · TERMINATED · started Dec 3, 2019ClinicalTrials.gov NCT04115748 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD TherapyPHASE3 · TERMINATED · started Nov 13, 2019ClinicalTrials.gov NCT04115839 · fetched Nov 12, 2026
- A Clinical Study to Test Long Term Safety of GLPG1690 for Patients With Systemic SclerosisPHASE2 · TERMINATED · started Jul 18, 2019ClinicalTrials.gov NCT03976648 · fetched Nov 12, 2026
- A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Systemic SclerosisPHASE2 · COMPLETED · started Jan 14, 2019ClinicalTrials.gov NCT03798366 · fetched Nov 12, 2026
- A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of CarePHASE3 · TERMINATED · started Nov 28, 2018ClinicalTrials.gov NCT03711162 · fetched Nov 12, 2026
- A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of CarePHASE3 · TERMINATED · started Nov 5, 2018ClinicalTrials.gov NCT03733444 · fetched Nov 12, 2026
- A Study to Assess Efficacy and Safety of GLPG1972/S201086 in Participants With Knee OsteoarthritisPHASE2 · COMPLETED · started Aug 14, 2018ClinicalTrials.gov NCT03595618 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious UveitisPHASE2 · TERMINATED · started Jul 26, 2017ClinicalTrials.gov NCT03207815 · fetched Nov 12, 2026
- Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel DiseasePHASE2 · TERMINATED · started Jul 11, 2017ClinicalTrials.gov NCT03201445 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)PHASE2 · COMPLETED · started Apr 11, 2017ClinicalTrials.gov NCT03046056 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's DiseasePHASE2 · COMPLETED · started Apr 6, 2017ClinicalTrials.gov NCT03077412 · fetched Nov 12, 2026
- Filgotinib in Long-Term Extension Study of Adults With Crohn's DiseasePHASE3 · TERMINATED · started Mar 17, 2017ClinicalTrials.gov NCT02914600 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative ColitisPHASE3 · COMPLETED · started Nov 14, 2016ClinicalTrials.gov NCT02914522 · fetched Nov 12, 2026
- Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's DiseasePHASE3 · COMPLETED · started Oct 31, 2016ClinicalTrials.gov NCT02914561 · fetched Nov 12, 2026
- Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to MethotrexatePHASE3 · COMPLETED · started Aug 30, 2016ClinicalTrials.gov NCT02889796 · fetched Nov 12, 2026
- Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX TherapyPHASE3 · COMPLETED · started Aug 8, 2016ClinicalTrials.gov NCT02886728 · fetched Nov 12, 2026
- Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) TreatmentPHASE3 · COMPLETED · started Jul 27, 2016ClinicalTrials.gov NCT02873936 · fetched Nov 12, 2026
- Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis ParticipantsPHASE2 · COMPLETED · started Feb 25, 2014ClinicalTrials.gov NCT02065700 · fetched Nov 12, 2026